As of 2024-12-13, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (11.00) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.01 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -319.6%.
The range of the Relative Valuation is (12.86) - (13.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 17.5x | 17.3x |
| Forward P/E multiples | 5.1x - 18.8x | 12.0x |
| Fair Price | (12.86) - (13.16) | (11.00) |
| Upside | -356.8% - -362.8% | -319.6% |
| Date | P/E |
| 2024-11-29 | -6.51 |
| 2024-11-27 | -6.57 |
| 2024-11-26 | -6.38 |
| 2024-11-25 | -6.61 |
| 2024-11-22 | -6.45 |
| 2024-11-21 | -6.39 |
| 2024-11-20 | -6.33 |
| 2024-11-19 | -6.57 |
| 2024-11-18 | -6.25 |
| 2024-11-15 | -5.60 |
| 2024-11-14 | -5.68 |
| 2024-11-13 | -5.86 |
| 2024-11-12 | -6.32 |
| 2024-11-11 | -7.30 |
| 2024-11-08 | -7.34 |
| 2024-11-07 | -7.10 |
| 2024-11-06 | -7.18 |
| 2024-11-05 | -7.01 |
| 2024-11-04 | -6.89 |
| 2024-11-01 | -7.13 |
| 2024-10-31 | -6.99 |
| 2024-10-30 | -7.10 |
| 2024-10-29 | -7.21 |
| 2024-10-28 | -7.47 |
| 2024-10-25 | -7.08 |
| 2024-10-24 | -7.15 |
| 2024-10-23 | -7.31 |
| 2024-10-22 | -7.84 |
| 2024-10-21 | -7.35 |
| 2024-10-18 | -7.58 |
| 2024-10-17 | -7.38 |
| 2024-10-16 | -7.39 |
| 2024-10-15 | -7.13 |
| 2024-10-14 | -7.23 |
| 2024-10-11 | -7.14 |
| 2024-10-10 | -7.07 |
| 2024-10-09 | -6.94 |
| 2024-10-08 | -6.98 |
| 2024-10-07 | -7.02 |
| 2024-10-04 | -7.10 |
| 2024-10-03 | -6.95 |
| 2024-10-02 | -7.05 |
| 2024-10-01 | -7.03 |
| 2024-09-30 | -7.17 |
| 2024-09-27 | -7.31 |
| 2024-09-26 | -7.14 |
| 2024-09-25 | -7.18 |
| 2024-09-24 | -7.51 |
| 2024-09-23 | -7.42 |
| 2024-09-20 | -7.83 |